Latest Breaking News On - Medicine inc - Page 5 : comparemela.com

Levin Capital Strategies L P Makes New $177,000 Investment in Prime Medicine, Inc (NYSE:PRME)

Levin Capital Strategies L.P. purchased a new position in Prime Medicine, Inc. (NYSE:PRME – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 20,000 shares of the company’s stock, valued at approximately $177,000. Other hedge funds have also recently modified their holdings of […]

Stifel nicolausRobert nelsenMedicine company profileOppenheimer coChina universal asset management coSg americas securitiesProfund advisorsMedicine incPrime medicineFree reportUniversal asset managementGet free reportDirector robert nelsenPrime editorsPrime editorVisit holdingschannel

Psychedelic Drug Market Poised to Hit $4 6B by 2030

Psychedelic Drug Market Poised to Hit $4 6B by 2030
hightimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hightimes.com Daily Mail and Mail on Sunday newspapers.

Celon pharmaRoche ltdCybin corpNeurorx incJazz pharmaceuticals incJanssen pharmaceuticalsMedicine incBrandessence market researchTherapeutics incHikma pharmaceuticalsPharmather incPfizer incJazz pharmaceuticalsMind medicineHydroxybutyric acidAcid diethylamide

Prime Medicine Announces FDA Clearance Of Investigational New Drug (IND) Application For PM359 For The Treatment Of Chronic Granulomatous Disease (CGD

Prime Medicine Announces FDA Clearance Of Investigational New Drug (IND) Application For PM359 For The Treatment Of Chronic Granulomatous Disease (CGD
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesHannah deresiewiczKeith gottesdienerExchange commissionStern investor relations incDrug administrationEditing technologyMedicine incFirst ever openPrime editingPrime medicinePrevalent disease causing mutationData expectedInvestigational new drugPrime editor

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesKeith gottesdienerHannah deresiewiczEditing technologyDrug administrationStern investor relations incExchange commissionMedicine incFirst ever openPrime editingPrime medicinePrevalent disease causing mutationData expectedInvestigational new drugPrime editor

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday - Tesla (NASDAQ:TSLA)

Saudi arabiaUnited statesMary kay fentonKoninklijke philipsDavid joyceMultiplan corporationPacific biosciencesDavid ellisonAlbemarle corporationCalifornia incRoku incTesla incPhibro animal health corporationMmtec incMedifast incFulton bank